Ocular Therapeutix, Inc.

OCUL · Healthcare · Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases a…

Ocular Therapeutix, Inc. (OCUL), in the Healthcare sector, has 12 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 1 purchase and 11 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 24 and filed Aug 26. The most active filer was Pravin Dugel with 9 filings.

Add to watchlist

Filings, ttm

1 buy · 11 sells

Traders, ttm

8 insiders

Volume, ttmiDollar value disclosed in the window

$3.3M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 24

Filed Aug 26

ADViAverage daily dollar volume

$29.3M

market data

Share price · 12M

$10.36 (-15.1%)

Adjusted for splits and dividends.

Volume by month

Buys $461K Sells $3.7M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Pravin Dugel See Remarks 9 filings NW

Nadia Waheed Chief Medical Officer 2 filings TA

Todd Anderman Chief Legal Officer 1 filing JH

Jeffrey S. Heier Chief Scientific Officer 1 filing PK

Peter Kaiser Chief Development Officer 1 filing RL

Richard L Md Lindstrom Director 1 filing DN

Donald Notman Chief Operating Officer 1 filing NS

Namrata Saroj Chief Business Officer 1 filing

Recent filings

Pravin DugelSALE See Remarks $233K
21,649 sh × $10.77
Exec Aug 24
Filed Aug 26 · 5:56 PM ET Nadia WaheedSALE Chief Medical Officer $123K
14,828 sh × $8.27
Exec Jun 3
Filed Jun 5 · 5:30 PM ET Pravin DugelSALE See Remarks $173K
21,156 sh × $8.20
Exec May 26
Filed May 28 · 5:30 PM ET Pravin DugelSALE See Remarks $166K
20,056 sh × $8.28
Exec Feb 23
Filed Feb 25 · 5:30 PM ET Richard L Md LindstromPURCHASE Director $461K
60,229 sh × $7.66
Exec Feb 20
Filed Feb 24 · 6:13 PM ET Pravin DugelSALE See Remarks $1.1M
124,882 sh × $9.04
Exec Feb 12
Filed Feb 17 · 5:30 PM ET Donald NotmanSALE Chief Operating Officer $103K
11,446 sh × $9.04
Exec Feb 12
Filed Feb 17 · 5:30 PM ET Pravin DugelSALE See Remarks $235K
19,530 sh × $12.04
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET Namrata SarojSALE Chief Business Officer $278K
25,865 sh × $10.74
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET Todd AndermanSALE Chief Legal Officer $137K
11,132 sh × $12.34
Exec Oct 8 2025
Filed Oct 10 2025 · 5:30 PM ET Jeffrey S. HeierSALE Chief Scientific Officer $116K
10,502 sh × $11.04
Exec Oct 2 2025
Filed Oct 6 2025 · 5:30 PM ET Peter KaiserSALE Chief Development Officer $106K
9,653 sh × $11.03
Exec Oct 2 2025
Filed Oct 6 2025 · 5:30 PM ET Pravin DugelSALE See Remarks $259K
21,494 sh × $12.04
Exec Aug 25 2025
Filed Aug 27 2025 · 5:30 PM ET Nadia WaheedSALE Chief Medical Officer $112K
13,861 sh × $8.05
Exec Jun 2 2025
Filed Jun 3 2025 · 5:30 PM ET Pravin DugelSALE See Remarks $152K
21,219 sh × $7.18
Exec May 23 2025
Filed May 27 2025 · 5:30 PM ET Pravin DugelSALE See Remarks $148K
21,475 sh × $6.87
Exec Feb 24 2025
Filed Feb 26 2025 · 5:30 PM ET Pravin DugelSALE See Remarks $186K
20,680 sh × $9.01
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET